Dade Behring (NASDAQ:DADE) and Premier announced that they have signed a multi-year agreement in which Premier, one of the largest group purchasing organizations in the United States, has agreed to a three-year contract for Dade Behring's MicroScan(R) microbiology instruments and reagents. This agreement is in addition to the announcement earlier this year of an agreement between Premier and Dade Behring for Dimension chemistry systems, StreamLab automation systems, Stratus(R) CS, Syva(R) Emit tests and hemostasis tests. Dade Behring is a worldwide leader in the field of diagnostics.
"The extension of our microbiology business with Premier reflects the very positive partnership we have developed together through the years," said Jim Reid Anderson, Chairman, President and CEO, Dade Behring. "It also ensures that Premier's members--and their patients--have our commitment to provide them with the best clinical diagnostics to improve the quality of health care."
About Premier
Premier, Inc. is a strategic alliance in U.S. healthcare, entirely owned by more than 200 of the nation's leading hospital and healthcare systems. These systems operate or are affiliated with nearly 1,500 hospital facilities and hundreds of other healthcare sites. Premier provides an array of resources supporting health services delivery including group purchasing for more than $17 billion annually in supplies and equipment. Other resources offered by Premier are supply chain and clinical performance improvement services and insurance programs. Premier is headquartered in San Diego, CA. with other major facilities in Chicago, IL and Charlotte, NC. Advocacy and policy offices are located in Washington, DC. For more information visit www.premierinc.com.
About Dade Behring
With 2003 revenues of more than $1.4 billion, Dade Behring is the world's largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the internet at www.dadebehring.com.